Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Obesity (Disorder) peptide trials
4 selected ClinicalTrials.gov records carrying the official condition label Obesity (Disorder). The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
4 selected records.
1 profiles.
2026–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 75 selected PubMed records and 2 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Obesity (Disorder) unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT07504172
PeptideScanner retained ClinicalTrials.gov record NCT07504172 at 2026-11-14T22:51:22.481Z. Its registry update date was 2026-10-28, and PeptideScanner's reviewed identity mapping was tirzepatide.
- PeptideScanner change date
- November 14, 2026
- Cited source date
- October 28, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT07929571
PeptideScanner retained ClinicalTrials.gov record NCT07929571 at 2026-11-14T22:51:22.481Z. Its registry update date was 2026-11-10, and PeptideScanner's reviewed identity mapping was tirzepatide.
- PeptideScanner change date
- November 14, 2026
- Cited source date
- November 10, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT07931235
PeptideScanner retained ClinicalTrials.gov record NCT07931235 at 2026-11-14T22:51:22.481Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was tirzepatide.
- PeptideScanner change date
- November 14, 2026
- Cited source date
- November 12, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Tirzepatide · 2026-11-12
ClinicalTrials.gov record NCT07931235
Not yet recruiting at the retained observation.
Open attributed record →Tirzepatide · 2026-11-10
ClinicalTrials.gov record NCT07929571
Not yet recruiting at the retained observation.
Open attributed record →Tirzepatide · 2026-10-28
ClinicalTrials.gov record NCT07504172
Completed at the retained observation.
Open attributed record →Tirzepatide · 2026-07-22
ClinicalTrials.gov record NCT07257484
Recruiting at the retained observation.
Open attributed record →